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Summary
The extreme diversity in substrate specificity, and in
the regulation mechanism of arogenate/prephenate
dehydrogenase enzymes in nature, makes a compara-
tive structural study of these enzymes of great inter-
est. We report here on the biochemical and structural
characterization of arogenate dehydrogenase from
Synechocystis sp. (TyrAsy). This work paves the way
for the understanding of the structural determinants
leading to diversity in substrate specificity, and of
the regulation mechanisms of arogenate/prephenate
dehydrogenases. The overall structure of TyrAsy in
complex with NADP was refined to 1.6 A˚. The asym-
metric unit contains two TyrAsy homodimers, with
each monomer consisting of a nucleotide binding N-
terminal domain and a particularly unique a-helical
C-terminal dimerizationdomain. Thesubstrate arogen-
ate was modeled into the active site. The model of the
ternary complex enzyme-NADP-arogenate nicely re-
veals at the atomic level the concerted mechanism of
the arogenate/prephenate dehydrogenase reaction.
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Tyrosine and phenylalanine are synthesized from pre-
phenate by two distinct routes in nature (Stenmark
et al., 1974): the arogenate route, or the p-hydroxyphe-
nylpyruvate/phenylpyruvate route (Figure 1). In the
arogenate route, prephenate is first transaminated into
arogenate, which is then transformed into tyrosine or
phenylalanine by arogenate dehydrogenase or arogen-
ate dehydratase, respectively. Alternatively, in the p-
hydroxyphenylpyruvate/phenylpyruvate route, prephen-
ate is first transformed by prephenate dehydrogenase
or prephenate dehydratase into p-hydroxyphenylpyru-
vate or phenylpyruvate, which are then transaminated
into tyrosine or phenylalanine, respectively. Further-
more, in several cases, a single dehydrogenase may cat-
alyze either the prephenate or the arogenate reaction
(Patel et al., 1977; Zhao et al., 1993).
A widespread combination of the alternative routes
can be found in nature, leading to a considerable diver-
sity in the biosynthesis of the aromatic amino acids,
tyrosine and phenylalanine. For example, in Escherichia
coli and yeast, the arogenate route is totally absent,
while in cyanobacteria, and several other microorgan-
isms, the arogenate-to-tyrosine/phenylpyruvate-to-
phenylalanine pathway is present (Fazel and Jensen,
1979; Hall et al., 1982; Keller et al., 1985; Mayer et al.,
1985). In other bacterial species (e.g., Pseudomonas
aeruginosa and Zymomonas mobilis), the alternative
pathways to tyrosine coexist (Patel et al., 1977; Zhao
et al., 1993). At the other end of the spectrum, in most
plants, arogenate is the exclusive precursor of both tyro-
sine and phenylalanine.
Regardless of the biosynthetic mode up to the branch
point, fine tuning is required to balance the flux of inter-
mediates between tyrosine and phenylalanine. Different
enzyme combinations render possible a wide variety of
control mechanisms, from direct competitive inhibition
with the substrate by the product of the reaction, to
complex multivalent allosteric feedback control by end
products (for a review, see Herrmann and Weaver,
1999; Schmid and Amrhein, 1995, 1999). In plants, the
situation is unique, because the branch point in the
pathway is at the level of arogenate. This may be ex-
plained by the respective importance of tyrosine and
phenylalanine in terms of carbon flux, which is quite dif-
ferent in plants than in other organisms. Phenylalanine is
the precursor of a myriad of secondary compounds,
termed phenylpropanoids. In certain conditions, not
less than 30% of the carbon fixed by photosynthesis is
incorporated into phenylalanine for the synthesis of phe-
nylpropanoids, such as lignin. In contrast, much less
carbon is incorporated into tyrosine. The partition of
the carbon flux between tyrosine and phenylalanine is
controlled by the high sensitivity of arogenate dehydro-
genase to inhibition by tyrosine, the reaction product
(Rippert and Matringe, 2002a, 2002b). Tyrosine exerts
a competitive inhibition with respect to arogenate, lead-
ing to the formation of a dead-end enzyme-tyrosine
complex. When it is required, the high affinity of the
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768Figure 1. Biosynthesis Pathways Leading to
Tyrosine and Phenylalanine from Prephenate
in Plant, Yeast, and Synechocystis
PreAT = prephenate aminotransferase;
PheAT = phenylalanine aminotransferase;
TyrAT = tyrosine aminotransferase.enzyme for tyrosine (Ki = 5mM) allows the cells to channel
the majority of the carbon from the postchorismate
pathway into the synthesis of phenylalanine and its phe-
nylpropanoid derivatives, such as lignin. Furthermore,
tyrosine positively regulates arogenate dehydratase
(Siehl and Conn, 1988). In Synechocystis, tyrosine is
also synthesized via arogenate. However, in this organ-
ism, arogenate dehydrogenase is not at the branch point
between tyrosine and phenylalanine, since phenylala-
nine is synthesized via phenylpyruvate by a prephenate
dehydratase (Fazel and Jensen, 1979; Hall et al., 1982;
Keller et al., 1985; Mayer et al., 1985). Accordingly, Syn-
echocystis arogenate dehydrogenase (TyrAsy) is much
less sensitive to tyrosine.
The extreme diversity in substrate specificity, and in
regulation mechanism of arogenate/prephenate dehy-
drogenases, makes a comparative structural study of
these enzymes of both evolutionary and mechanistic
significance. Determination of the X-ray crystallographic
structure of different arogenate/prephenate dehydroge-
nases will elucidate, at the atomic level, the structural
determinants leading to this diversity in substrate spec-
ificity and regulation mechanism. This work will allow for
future relevant engineering of new enzymes, with cus-
tomized kinetics properties, to modulate carbon flux
between tyrosine and phenylalanine. Furthermore, the
absence of these enzymes in the animal kingdom makes
the elucidation of arogenate/prephenate dehydroge-
nase X-ray crystallographic structures an invaluable
tool for the rational design of new inhibitors with antimi-
crobial, herbicidal, or fungicidal activities.
In this study, we report on the biochemical and struc-
tural characterization of arogenate dehydrogenase from
Synechocystis. To our knowledge, this work represents
the first elucidation of an X-ray crystallographic struc-
ture of an arogenate/prephenate dehydrogenase in
any kingdom. The kinetics properties of TyrAsy pre-sented in this study differ markedly, with respect to tyro-
sine sensitivity and reaction mechanism, from those re-
ported recently (Bonner et al., 2004). The high-resolution
structure of the binary complex enzyme-NADP structure
allowed us to propose a model of the ternary complex
enzyme-NADP-arogenate, which nicely reveals at the
atomic level the concerted mechanism of the arogen-
ate/prephenate dehydrogenase reaction.
Results
Purification of Arogenate Dehydrogenase
from Synechocystis Overexpressed in E. coli
A two-step procedure was devised to purify the re-
combinant TyrAsy. The procedure consisted of anion
exchange chromatography followed by dye-ligand affin-
ity chromatography, and resulted in an overall 6-fold pu-
rification, with a yield of enzyme activity of about 80%.
Thus, typically about 13 mg pure TyrAsy was obtained
from 100 mg of the soluble protein extract (Table 1).
In SDS-PAGE, the purified protein migrated as a single
polypeptide of about 32 kDa (Figure 2A), in agreement
with the value calculated from the amino acid sequence
predicted from the cDNA (30.2 kDa). In the presence of
saturating concentrations of the substrates arogenate
and NADP, the pure recombinant enzyme exhibited
a specific activity of 88–110 U/mg protein. The apparent
molecular mass of the native recombinant TyrAsy was
estimated both by acrylamide gel under nondenaturing
conditions and size exclusion chromatography. As
documented in Figure 2B, purified protein migrated for
the most part as a dimer of about 70 kDa. A minor
band of about 160 kDa, corresponding to a tetramer,
was also observed. Size exclusion chromatography us-
ing Superdex S75 confirmed that about 90% of TyrAsy
eluted with mobility, consistent with that of a dimeric









Crude extract 100 1410 14.1 100 1
EMD DEAE 650 (M) pool 41 1242 30.3 88 2.1
Red 120, agarose pool 12.8 1130 88.1 80.1 6.2
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of the Recombinant Enzyme
The dehydrogenase activity of TyrAsy was found to be
strictly arogenate- and NADP-dependent. Indeed, no
arogenate dehydrogenase activity was detected using
1 mM of NAD, and no prephenate dehydrogenase activ-
ity was detected using 1 mM of prephenate and 1 mM of
NADP or NAD.
TyrAsy activity was assayed for optimal pH by mea-
suring initial catalytic rates over a pH range of 5.5–9.0.
A broad pH profile was obtained, with a pH optimum
at 7.5 in 50 mM Tris-HCl, and enzyme activity dropping
below pH 6.5 and above pH 8.5. Kinetic analyses were
thus conducted in 50 mM Tris-HCl (pH 7.5).
The apparent kinetic constants for arogenate and
NADP were determined with pure recombinant TyrAsy
enzyme, as described in Experimental Procedures, by
varying the concentration of one of the two substrates
while keeping the other substrate at saturating levels.
Under these conditions, recombinant TyrAsy obeyed
Michaelis-Menten kinetics with respect to each sub-
strate. A Km of 9 mM was obtained for NADP, and
93 mM for arogenate. These Michaelis-Menten constants
are of the same order of magnitude as those determined
with purified enzyme from different organisms (Keller
et al., 1985, Mayer et al., 1985, Rippert and Matringe,
2002b). These Km values are slightly lower than those re-
ported by Bonner and coworkers in their biochemical
study of TyrAsy (Bonner et al., 2004).
As observed forArabidopsis thaliana arogenate dehy-
drogenase, when NADP is used at low concentrations
(between 4 and 12 mM), with arogenate as the variable
substrate, sigmoidal curves were obtained, indicating
positive kinetic cooperativity (nH = 1.4) with respect to
the binding of arogenate for both enzymes. When
NADP was the variable substrate, no kinetic cooperativ-
ity was observed.
Figure 2. Purification of the Recombinant Synechocystis Arogenate
Dehydrogenase
(A) SDS-PAGE stained with Coomassie brillant blue R-250 for the dif-
ferent polypeptide fractions. Lane 1: crude soluble extract (15 mg)
of E. coli BL21(lDE3) cells transformed with pET29-tyrAsy. Lane 2:
fraction containing TyrAsy eluted from EMD-DEAE 650 (M) column
(10 mg). Lane 3: fraction containing TyrAsy eluted from the Red 120
agarose column (5 mg). MW = molecular weight markers.
(B) Analyses of the oligomerization of TyrAsy. Purified TyrAsy was
analyzed by nondenaturating electrophoresis and stained with
Coomassie brillant blue R-250. Lane1: molecular weight markers.
Lane 2: fraction containing TyrAsy eluted from a Red 120 agarose
column (15 mg). A major and a minor polypeptide of 70 kDa and
160 kDa, respectively, are resolved.Effect of Tyrosine and Other Potential Effectors
on TyrAsy Activity
TyrAsy was assayed at various substrate concentra-
tions of arogenate, as low as 20 mM in the presence of
tyrosine up to 500 mM, in order to detect any possible
weak competitive inhibition. However, under our assay
conditions, the enzyme was found to be almost com-
pletely insensitive to feedback inhibition by tyrosine.
Phenylalanine and tryptophan were also assayed as
possible allosteric effectors, but no effects upon activity
were found at concentrations of up to 1 mM.
Overall Structure
The overall structure of TyrAsy was refined to 1.6 A˚. The
final R free value was 0.226, and the average B factor
was 22.8 A˚2 (see Table 2 for more details). The model
was of good quality, with all the residues falling in the
most favorable (91.2%) and additionally allowed region
(7.9%) of the Ramachandran plot (the stereochemistry
was assessed by PROCHECK [Laskowski et al., 1993]).
The asymmetric unit contains two TyrAsy homodimers
(Figure 3A). Each monomer consists of two distinct do-
mains (Figure 3C), an N-terminal domain corresponding
to a Rossmann fold that binds NADP, and an a-helical C-
terminal dimerization domain. Structural alignment of
the four monomers present in the asymmetric unit re-
veals flexibility between the N- and the C-terminal do-
mains, with a maximum rotation between the most
closed conformation (molecules B and D) and the most
open conformation (molecule C) of 11.6º. The rigid
body motion of the two domains is made possible by ar-
ticulation around a clear hinge between residues Thr166
and Pro167 (Figure 3).
Dimer Interface
The dimer interface is exclusively located in the C-termi-
nal domain (Figure 3B). This C-terminal dimerization do-
main, Pro167 to Glu279, consists of seven a helices
(from a6 to a12) overlapping with their respective dimer
mates. The core of this domain is formed by a first series
of two helices (a6 and a7), the five following helices turn-
ing around this core. The dimerization interface is
spread all along the C-terminal chain (Figure 3B), with
about 4020 A˚2 of each monomer surface buried, which
amounts to about 26.6% of each subunit surface area
(SURFACE program). This has to be compared to the
other contacts in the crystal packing. Apart from the in-
terface between the two members of the dimer, the
larger contact is located at the interface between the
two dimers that form the tetramer; 1442 A˚2 are buried
in this interface, which amounts to only about 6.5% of
each dimer surface.
Active Site: NADP Binding Site
The N-terminal domain, from Met1 to Thr166, corre-
sponds to a Rossmann fold with a b sheet extended to
eight strands (b1 to b8 [see Figure 3C], the two last
strands being antiparallel to the rest). Density was ob-
served in the unbiased Fo 2 Fc electronic map, at the
surface of the N-terminal domain, facing the C-terminal
domain. This density was used to build one NADP mol-
ecule per monomer (Figure 3). Interaction of the adenine
ring of NADP consists mainly of hydrogen bonds be-
tween the 20-phosphate oxygen atoms and Ser30,
Structure
770Table 2. Statistics of Data Collection and Processing
Data Sets
Data collection
Sample Pt derivative Native
Resolution, A˚ 30–2.6 (2.69–2.6) 30–1.55 (1.6–1.55)
Completeness, % 98.1 (89.7) 99.0 (92.2)
Rsym, %
a 4.6 (24.9) 4.6 (45.5)
I/s 12.55 (3.38) 16.69 (2.75)
Redundancy 1.93 (1.9) 4.08 (3.42)
Phasing
Resolution, A˚ 30–2.8 (2.87–2.8) —
Figures of merit, acentric/centric 0.302/0.069 (0.202/0.098) —
RCullis
b 0.84 (0.96) —
Phasing power 0.974 (0.505) —
Refinement
Resolution, A˚ — 20–1.55 (1.6–1.55)
Independent reflectionsc — 124,140 (8,138)
Number atoms of protein refinedd — 8,639
Number atoms of solvent refinedd — 425
Number atoms of ligand refinedd — 218
R fact.e, % — 18.9 (22.6)
R free,f % — 22.2 (27.0)
Value(s) for the highest resolution shell (1.60–1.66 A˚) are in parentheses.
a Rsym = SjIh 2 <Ih>j/SIh, where <Ih> is the average intensity over symmetry equivalent reflections.
b RCullis = Shkl(jFPH(obs)j 2 jFPH(calc)j)/Shkl(jFPH(obs)j 2 jFP(obs)j), sum only over acentric reflections.
c Number of independent reflections used during refinement (95% of the total number of reflection in resolution range).
d Includes multiple conformations.
e Rfact = ShkljFobs 2 Fcalcj/S hkljFobsj, where Fobs and Fcalc are, respectively, the measured and calculated structure factors.
f Rfree = same as Rfact, but calculated on the basis of 5% of total data randomly selected and omitted during structure refinement.Arg31, Gln32, and Thr35 side chain atoms, and Arg31
and Gln32 backbone nitrogen atoms. At the other end,
the O17 oxygen atom of the nicotinamide moiety forms
a hydrogen bond with oxygen of the Thr117 side chain.
In addition, the 20 oxygen of the ribose ring makes an-
other hydrogen bond with the side chain oxygen and
backbone nitrogen atoms of Ser92. This scheme is com-
pleted by hydrogen bonding between oxygen atoms of
the dinucleotide moiety and Leu10, Ile11, and Gly121
backbone nitrogen atoms and the side chain nitrogen
atom of Gln120 (Figure 4).
Active Site: Substrate Binding Site
The active site is located in a deep groove at the inter-
face of the NADP N-terminal binding domain and the
C-terminal domains (Figures 3B and 3C). It is formed
by residues His112–Ala119 (a loop between b6 and
h3), Ile177–Val182 (a short turn between a6 and a7),
and Gly221–Met229 (part of helix a10, facing the groove
between the two domains). Furthermore, Leu207–
Gly211 (end of helix a8 and the loop between helices
a8 and a9) from the other molecule of the dimer also par-
ticipate in the formation of the active site.
Discussion
Kinetic Analyses
Our kinetic analyses of TyrAsy revealed that its kinetic
properties are very similar to the kinetic properties of
plant arogenate dehydrogenases (Rippert and Matringe
2002b). As for the Arabidopsis arogenate dehydroge-
nase enzymes (Rippert and Matringe 2002b) and
E. coli chorismate mutase/prephenate dehydrogenase
bifunctional enzyme (Sampathkumar and Morrisson,1982), positive kinetic cooperativity in the binding of ar-
ogenate was observed, indicating that NADP increases
the apparent affinity of the Synechocystis enzyme for ar-
ogenate. However, arogenate did not alter the affinity of
the enzyme for NADP (Table 1). The main difference be-
tween the plant and Synechocystis TyrAsy enzymes lies
in their affinity for tyrosine, the product of the arogenate
dehydrogenase reaction. Indeed, plant arogenate dehy-
drogenases are very sensitive to competitive inhibition
by tyrosine with respect to the arogenate substrate
(Ki z 5 mM) (Connely and Conn, 1986; Rippert and
Matringe, 2002b). In the present study, the TyrAsy was
found to be nearly insensitive to tyrosine, at tested con-
centrations. A similar result was also observed for ar-
ogenate dehydrogenase from A. missouriensis (Hund
et al., 1989), and other strains of Synechocystis (Hall
et al., 1982). Our kinetic results thus differ, with respect
to the tyrosine sensitivity and to the cooperativity for the
binding of arogenate, with those reported recently (Bon-
ner et al., 2004). These discrepancies between the two
studies are difficult to explain since in both cases the
same Synechocystis strain PCC 6803 was used. The
main difference between the two recombinant enzymes
was the presence of mutations at the C-terminal in the
sequence of the recombinant protein they cloned
(LQHRLLQTN) with respect to the database sequence
and our recombinant protein (LHRLLQQTN). These
four mutations, H264Q, R265H, L266R and Q268L, are
localized in the a12 helix. Among these mutations,
H264Q would be of particular importance as His264 in-
teracts with a10 of the other monomer. Because a10 be-
longs to the active site (see active site and reac-
tion mechanism), mutation of His264 could affect the
catalytic properties of the enzyme and its sensitivity to
tyrosine.
Crystal Structure of the Arogenate Dehydrogenase
771Figure 3. Structure of Synechocystis Arogenate Dehydrogenase
(A) Ribbon diagram of TyrAsy tetramer in complex with NADP. Monomers A and B are shown in gold and blue, respectively. Monomers C and D
are shown in red.
(B) Ribbon diagram of TyrAsy dimer in complex with NADP. Monomers A and B are shown in gold and blue, respectively. The figure shows the
C-terminal a-helical dimerization domain and the deep groove between the NADP N-terminal domain and the dimerization domain.
(C and D) Two views of TyrAsy monomer A. The N-terminal and C-terminal domains are depicted in yellow-gold and green-gold, respectively.
Secondary structures are indicated. In all four panels, NADP molecule is depicted as sticks. Diagrams were produced with MOLSCRIPT (Kraulis,
1991) and rendered with POV-RAY (http://www.povray.org).Dimer Organization and Structure Comparisons
In good agreement with gel filtration and native PAGE
experiments which indicate that TyrAsy behaves
predominantly as an homodimer and in minority as a tet-
ramer, the asymmetric unit contains two TyrAsy homo-
dimers. Each monomer consists of a nucleotide binding
N-terminal domain and a particularly unique a-helical
C-terminal dimerization domain. Indeed, not less than
26.6% of each subunit surface area, and 43% of the
C-terminal surface area, is involved in dimer interac-
tions. This is particularly high compared to the values
found in the literature, which commonly range from
6.5% to 29.4% (Jones and Thornton, 1995). A similar
structural organization is also found in the human heart
short chain L-3-hydroxyacyl coenzyme A dehydroge-
nase (SCHAD; PDB id: 2HDH; rms distance between
Ca atoms after structural alignment of the full length
monomers using DALI server: 3.3 A˚, for the 217 aligned
amino acids). Despite a low sequence similarity with
TyrAsy (only the first 100 residues can be aligned, with
25% identity), SCHAD exhibits an equivalent dimeric
structure (Barycki et al., 1999), each monomer consist-
ing of an N-terminal Rossmann fold type domain and
a primarily a-helical C-terminal dimerization domain.
However, while the N-terminal domains are very similar,
the C-terminal domains differ dramatically, exhibiting
a more classical surface dimerization (12.3% of each
monomer surface buried) for SCHAD, compared to the
complex dimerization of TyrAsy. Structure comparisonalso revealed that the N-terminal domain of TyrAsy is
similar to the 6-phosphogluconate dehydrogenase
N-terminal domain (rms distance between Ca atoms,
restricted to the N-terminal domain of TyrAsy, after
structural alignment using DALI server: 2.3 A˚ for the
143 aligned amino acids), with a b sheet extended to
eight strands, the two last strands being antiparallel to
the rest.
In spite of the low similarity between the arogenate/
prephenate dehydrogenase sequences, sequences
comparisons (Figure 5), and secondary structure as-
signment show that all these enzymes exhibit a common
NADP N-terminal domain followed by an a-helical C-ter-
minal domain. This strongly suggests the presence of
a similar domain interface for all arogenate/prephenate
enzymes.
Active Site and Reaction Mechanism
The reaction mechanism of arogenate or prephenate de-
hydrogenase consists of an hydride transfer and decar-
boxylation of the substrate carboxyl group. The reaction
mechanism determined in the present study for TyrAsy
is very similar to that of the E. Coli prephenate dehydro-
genase (Sampathkumar and Morrisson, 1982) and the
Arabidopsis arogenate dehydrogenases (Rippert and
Matringe 2002b). All three enzymes conform to a rapid
equilibrium random mechanism, with catalysis as the
rate-limiting step. pH profiles of all these prephenate
and arogenate dehydrogenases are very similar, with
Structure
772a drop in activity below pH 6.5 and above pH 8.5. Impli-
cation of a catalytic group with pKa = 6.5, likely histidine,
was first proposed by Hermes et al. (1984). The partici-
pation of a conserved histidine residue in the reaction
mechanism was later confirmed by site-directed muta-
genesis of the E. coli enzyme (His197 [Christendat
et al., 1998]). Hydride transfer and decarboxylation
could be either stepwise with the appearance of a dien-
one intermediate, as described for malic enzyme, iso-
citrate dehydrogenase, and 6-phosphogluconate dehy-
drogenase (Hermes et al., 1982), or concerted. Using 13C
kinetic isotope effects on decarboxylation of both deu-
terated and undeuterated substrate and substrate ana-
logs, Hermes and coworkers reported the presence of
a concerted reaction mechanism (Hermes et al., 1984)
(Figure 6). These authors hypothesized the presence of
a hydrophobic pocket at the level of the carboxyl group,
explaining the concerted reaction mechanism. Indeed,
under these conditions, the lifetime of the dienone inter-
mediate becomes so short that C-C cleavage occurs in
the same transition state as the hydride transfer (Fig-
ure 6).
The crystal structure reveals the presence of a water
molecule, W43, located within 2.51 A˚ of His112, the con-
served residue (corresponding to His197 in E. coli)
shown to be involved in the dehydrogenase reaction
Figure 4. NADP Binding Site
All molecular interactions less than 3.3 A˚ are shown. This figure was
prepared with Ligplot (Wallace et al., 1995).(Christendat et al., 1998). In addition, W43 also interacts
(3.8 A˚) with carbon C4 of NADP involved in the hydride
exchange. The substrate arogenate was positioned in-
side the active site by replacing the W43 with its hy-
droxyl residue (2.51 A˚ of His112). Its position was opti-
mized such that the exchanged hydride of its carbon 4
pointed toward the C4 of the oxidized nicotinamide at
2.6 A˚ (Figure 7A). In this optimized position, the carboxyl
residue of arogenate is facing the a10 helix of the active
cavity. Several hydrophobic amino acids residues of a10
(Leu225, Met228, and Met229), and residues Val182 and
Val218, are pointing toward the carboxyl group of ar-
ogenate (Figure 7A). These hydrophobic residues likely
represent the hydrophobic pocket predicted by Hermes
et al. (1984). Furthermore, His112 interacts with His170
and Asp171 (Figure 7A). Here, His112 facilitates hydride
transfer by beginning to accept the proton of the
4-hydroxyl group of arogenate prior to the beginning
of C-C cleavage, but cannot abstract this proton, thus
preventing the appearance of the dienone intermediate.
In summary, modeling of arogenate in the active site in
interaction with both His112 and the C4 of NADP is in
agreement with previous biochemical studies. It
strongly suggests that there is no structural rearrange-
ment induced by the binding of arogenate to the binary
complex enzyme-NADP, at least in the region of the
active site. This finding agrees well with the fact that
the reaction catalyzed by TyrAsy is random. Our model
of the ternary complex enzyme-NADP-arogenate could
thus nicely explain the concerted mechanism at the
atomic level.
The X-ray structure of TyrAsy shows that Arg217,
which correspond to Arg294 of the E. coli bifunctional
enzyme, is too far from the active site to play a role in
the binding of the substrate as proposed by Christendat
and Turnbull (1999). This is in good agreement with the
absence of this arginine in all plant arogenate dehydro-
genases. Finally, the present model of the enzyme-
NADP-arogenate ternary complex invalidates the partic-
ipation of a group with a pKa value of 8.8 in the binding of
the side chain carboxylate of the substrate, which was
proposed by Christendat and Turnbull (1999). Interest-
ingly, several amino acids of one dimer participate in
the active site of the other dimer molecule; in particular,
residues Leu207–Gly211 (end of helix a8 and the loop
between helices a8 and a9) (Figure 7C). This participa-
tion could explain the positive kinetic cooperativity in
the binding of arogenate that we observed.
We have noticed the presence of a patch of basic res-
idues, including Arg213, Arg217, and Arg274, on the sur-
face of the C-terminal domain located between the two
active-site clefts of the dimer. As these residues are
close to the noncrystallographic 2-fold axis, this patch
is effectively composed of six arginines. Further apart,
two more basic residues (Lys202 and Lys276) surround
the active-site cleft. The substrate having a net negative
charge (two carboxylate groups and one ammonium
group), this patch of basic residues could act as an elec-
trostatic attracting peripheral site for the substrate. How-
ever, as already mentioned, Arg217 is not present in
plant TyrA. Furthermore, Arg213 is replaced by aspara-
gine in all plant sequences, but the Synechococus en-
zyme has a serine and the E. coli enzyme has an alanine
at this position. Similarly, Lys202 and 276 are not
Crystal Structure of the Arogenate Dehydrogenase
773Figure 5. Sequence Alignment of Arogenate/Prephenate Deshydrogenase
Only sequences of characterized arogenate and prephenate dehydrogenases are used. The alignment is truncated at the N- and C-terminal res-
idues of TyrAsy. Secondary structure of TyrAsy is displayed on the top of the alignment. This figure was prepared with ESPript (Gouet et al.,
1999).conserved. It thus appears that this patch of basic resi-
dues does not play an essential role in the binding of
the substrate.
Prephenate/Arogenate Selectivity
Sequence alignment of characterized arogenate/pre-
phenate dehydrogenases (Figure 5) did not reveal any
obvious consensus motif for each activity. However,
based on the structural information for residues that
are likely to be involved in the arogenate/prephenate
binding site, a few residues in the C-terminal domain
may be responsible for substrate selectivity (Figure 7C).
The first one is His179, located in a highly conserved re-
Figure 6. Reaction Mechanism
The reaction mechanism scheme presented here is the concerted
mechanism proposed by Hermes et al. (1984). This figure was pro-
duced with ChemDraw.gion among all the arogenate/prephenate dehydroge-
nases. His179 is consistently replaced by an alanine in
the two prephenate dehydrogenases. A second series
of residues (Gly219, Gly221, Gly226, Met228, and
Tyr232) seems to play a role in substrate recognition.
Most of these residues are located on helix a10 facing
the groove between the two domains. These residues,
in particular Gly221, seem to be key for substrate selec-
tivity. Homology models of arogenate/prephenate dehy-
drogenases, based on the sequence alignment (Figure 5)
and the structure of TyrAsy, were also built. They reveal
that the residue in prephenate dehydrogenase, at an
equivalent position to Gly221 (Gln199 for E coli, and
Asn221 for S. cerevisiae), presents a nitrogen atom to-
ward the N atom of arogenate at a distance of about
4 A˚. Such an environment is likely more specific for inter-
action with a prephenate than with an arogenate mole-
cule (Figure 7C). In contrast, enzymes that can use
arogenate as a substrate possess at this position a
Gly, an Asp, or a Ser residue that can interact more eas-
ily with the N atom of arogenate. Site-directed mutagen-
esis studies, and elucidation of the X-ray crystallo-
graphic structure of a prephenate dehydrogenase, will
help to clarify this point.
Experimental Procedures
Engineering of Expression Vector
The pET29-tyrAsy plasmid coding for Synechocystis sp. PCC 6803
arogenate dehydrogenase was constructed by means of PCR
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plex Enzyme-NADP
(A) Representation of the active site of monomer A with arogenate
inside. Arogenate was positioned inside the active site by replacing
the W43 with its hydroxyl residue. The exchanged hydride of arogen-
ate carbon 4 points toward the C4 of the oxidized nicotinamide at
2.6 A˚. In this optimized position, the carboxyl residue of arogenate
is facing the a10 helix. Several hydrophobic aminoacids residues,
Leu225, Met228, and Met229, are pointing toward the carboxyl
group of arogenate. The potential hydrogen bonds of arogenate
with His112 and NADP are indicated by dashed lines. The diagram
was produced with MOLSCRIPT (Kraulis, 1991) and rendered with
POV-RAY (http://www.povray.org).
(B) Semitransparent charge-colored surface of the TyrAsy monomer
A active site with NADP and arogenate modeled as sticks inside.
Residues Leu225, Met228, and Met229 are also represented as
sticks, with carbons shown in cyan. Positive charges are depicted
in blue, negative in red, and sulfur atoms in orange. This figure
was produced with PyMOL (http://www.pymol.org).
(C) Representation of the active site of monomer A illustrating resi-
dues potentially involved in prephenate/arogenate selectivity. The
amino acid residues of monomer A located close to the arogenate
molecule are represented in blue. The ones from monomer B that
participate in the active site of monomer A (Leu207 and Gly211)cloning with aSynechocystis sp. PCC 6803 genomic DNA library as a
template. The PCR fragment corresponding to the tyrAsy coding
sequence (accession number D90910.1) was obtained with the fol-
lowing two oligonucleotides: 50-CTTGAAATCATATGAAAATTGG
TGTTGTTGG-30, which introduced an NdeI restriction site (under-
lined) at the ATG codon, and 50-ATTCTCCAGGCGATCGCCATTGGT
TTATTC-30. The PCR fragment was cloned into the plasmid pZero
(Invitrogen) previously digested with EcoRV. The NdeI-EcoRI DNA
fragment containing the tyrAsy coding sequence was cloned into
the plasmid pET29 a(+) (Novagen), yielding the plasmid pET29-
tyrAsy. Sequencing of the entire insert was carried out and was in
complete agreement with the expected sequences.
The E. coli BL21(lDE3) strain transformed with pET29-tyrAsy was
grown at 37ºC in Luria-Bertani medium supplemented with kanamy-
cin (50 mg/ml). When A600 reached 0.6, 0.4 mM of isopropylthio-b-D-
galactoside (Bioprobe system) was added to induce recombinant
protein synthesis, and growth was continued at 37ºC for 3 hr. Cells
were collected by centrifugation, resuspended in buffer A (50 mM
Tris-HCl [pH 7.5], 1 mM EDTA, 1 mM dithiothreitol, 1 mM benzami-
dine HCl, 5 mM amino caproic acid), and disrupted by sonication
with a Vibra-cell disruptor (Sonics and Materials, Danbury, CT)
(100 pulses every 3 s on power setting 5). The soluble extract was
obtained by a 15 min centrifugation at 40,0003 g to remove cellular
debris.
Purification of Recombinant TyrAsy
Soluble TyrAsy protein was applied to a Fractogel EMD DEAE 650
(M) column (2.6 3 35 cm; Merck) previously equilibrated in buffer
A. After the column had been washed with buffer A, proteins were
eluted with a 500 ml linear gradient from 0 to 0.5 M NaCl in buffer
A. Fractions containing the arogenate dehydrogenase activity
were pooled, concentrated to 2.5 ml with Macrosep-10 tubes (Fil-
tron), and desalted on PD10 Sephadex G25 columns.
Thedesaltedprotein extractwas loaded onto a Red120 agarosecol-
umn (1.63 20 cm; Sigma) previously equilibrated in buffer A. The col-
umn waswashed extensively, and theenzyme waselutedwith a 100 ml
linear gradient from 0 to 2 M NaCl in buffer A. The active fractions were
pooled, concentrated with Macrosep-10 tubes (Filtron), and desalted
on PD10 Sephadex G25 columns. Pure enzyme was stored for several
months at 4ºC until use, without loss of activity.
In order to determine the oligomerization state of the TyrAsy re-
combinant enzyme, the purified enzyme was applied to a Hiload
Superdex S 75 (1.6 3 60 cm; Pharmacia) connected to a Pharmacia
FPLC system previously equilibrated in buffer B (50 mM TrisHCl [pH
7.5], 1 mM DTT, 1 mM EDTA, 150 mM NaCl). The native mass of the
purified recombinant arogenate dehydrogenase was determined by
comparison with a standard curve obtained by separation under
similar conditions of the following molecular mass standards: BSA
(67 and 134 kDa), Maltose binding protein (45 kDa), Chymotrypsino-
gen A (25 kDa), and Ribonuclease A (13.7 kDa).
Total protein concentration was determined with the Bio-Rad pro-
tein assay with g-globulin as the standard, as described by Bradford
(1976). The concentration of purified arogenate dehydrogenase was
also determined by measuring the absorbance at 205 nm (Scopes,
1974).
Electrophoretic Analyses of Proteins and Enzyme Activity
For analysis of the protein purification, polypeptides were separated
by SDS-PAGE containing 12% (w/v) acrylamide, and visualized by
staining with Coomassie Brilliant Blue R250. PAGE was carried out
at equilibrium in the absence of any denaturing agent (SDS or
DTT), as described by Lasky (1978), on a linear acrylamide gradient
(3.5%–27.0%) with a 3.5% acrylamide stacking gel.
Prephenate and arogenate dehydrogenase activities were as-
sayed according to Bonner and Jensen (1987), at 25ºC by following
the formation of NADH or NADPH at 340 nm in a buffer containing
are represented in purple. Residue Gly221 of TyrAsy corresponds
to Gln199 and Asn221 (shown in brown) in the E. coli and S. cere-
visiae prephenate dehydrogenase sequences, respectively (see
Figure 4). These E. coli and S. cerevisiae residues could better ac-
commodate prephenate than arogenate, and thus could be involved
in substrate specificity of arogenate/prephenate dehydrogenases.
Crystal Structure of the Arogenate Dehydrogenase
77550 mM Tris-HCl [pH 7.5], 300 mM prephenate (Sigma) or arogenate
synthesized enzymatically from prephenate and purified as de-
scribed by Rippert and Matringe (2002b), and 1 mM NAD or NADP
in a total volume of 200 ml. Enzyme activity is expressed as U/mg,
where a Unit is defined as a mmol of NAD(P)H formed per minute
per milligram of protein. Kinetic data were fitted to the appropriate
rate equations by nonlinear regression analysis with the Kaleida-
Graph program (Abelbeck Software).
Arogenate Dehydrogenase Crystallization, X-Ray Data
Collection, and Processing
Crystals were grown in 5 ml sitting drops containing 2 ml protein mix
(14 mg/ml protein in 20 mM tris-HCl [pH 8.0]) plus 1 ml reservoir (PEG
6000 30%, 0.1 M tris-HCl [pH 8.0]) plus 2 ml of 2 mM NADP. Crystals
appeared in 2 days at 20ºC, and belonged to space group P21 with
four molecules per asymmetric unit. Crystals were placed directly
in Paratone-N oil for cryoprotection. Platine derivative was obtained
by soaking crystal in 1 mM K2PtCl4 during 1 week. All data sets
where collected at 100K, at the European Synchrotron Radiation
Facility (ESRF) on ID14-4 beamline. Data were integrated and scaled
using the XDS and XSCALE programs (December 2003 version
[Kabsch, 1993]). Data statistics are provided in Table 2. The SAD
data collection used for phasing was recorded at the peak of the
platinum LIII absorption spectrum (1.07181 A˚).
Structure Determination and Refinement
The TyrAsy structure was solved by the SAD method, with a Pt de-
rivative. The positions of the four Pt sites were readily obtained
with the SHELXD program (Schneider and Sheldrick, 2002). Due to
the low phasing power of this derivative and the very low solvent
content of this crystal form, the SAD phases calculated after refine-
ment of the sites with the program SHARP (de la Fortelle and Bri-
cogne, 1997) gave noninterpretable electron density maps, even
after solvent flattening. However, the first noncrystallographic sym-
metry operator from these phases was found with FFFEAR (Cowtan,
1998) by the following procedure: a subset of a solvent-flattened
map was extracted using crude masks centered around the region
of supposed protein density and used as a search model. The
best FFFEAR-ranked noncrystallography symmetry (NCS) operators
where then selected by their ability to improve phases through den-
sity averaging using DM (Cowtan, 1994). At this stage, a template
Rossman fold domain (from PDB no. 1I36) could be positioned in
the 2-fold NCS-averaged solvent-flattened maps. This led to the elu-
cidation of the two other NCS operators. The partial model that
could be built in the 4-fold-averaged solvent-flattened maps could
be transferred to a nonisomorph high-resolution native data set. A
more complete model could then be obtained by automatic tracing
with the program ARP/wARP (Perrakis et al., 1999). The structure
was then rebuilt with O (Jones et al., 1991) and refined using Refmac
(Murshudov et al., 1997), with 5% of the data set aside as a free set.
During refinement process, tight noncrystallographic symmetries
were progressively released, allowing at the end an independent
adjustment of the two domains in each monomer. Solvent sites
were identified with CCP4 programs (CCP4, 1994). The structure
was deposited in the PDB (PDB no. 2F1K).
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